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Dr. Fendrick is director of the Center for
Value-Based Insurance Design at the
University of Michigan where he oversees
the center’s role in leading and advocating
for the development, implementation, and
evaluation of innovative health benefit plans.
Value-Based Insurance Design (V-BID) is
described by the Center as plans that “align
patients’ out-of-pocket costs, such as copayments, with the value of the services…
and is built on the principle of lowering
or removing financial barriers to essential,
high-value clinical services.”1 Dr. Fendrick’s
research focuses on how clinician payment
and consumer engagement initiatives
impact access to care, quality of care, and
health care costs.
Dr. Fendrick strongly believes in shifting
the discussion from “how much” we are
spending on health care to “how well” we
are spending on health care. How does
this happen? He first described ways in
which research should be translated into
policy. For example, innovations to prevent

and treat disease have led to reductions
in morbidity and mortality; despite these
advances, cost growth is the main focus of
healthcare reform discussions. Additionally,
underutilization of high-value services
persists despite evidence of clinical benefits.

they produce, in the setting of a payment
and benefit design system that doesn’t
acknowledge them.” Implementation of
clinical nuance sets the consumer costsharing level based on the clinical benefit,
not the acquisition price of the service.

Fendrick explained that consumer costsharing is key to encouraging clinically
appropriate use of health services. There is
growing evidence that increases in costsharing leads to a reduction in the use of
essential services and impacts behavior in
healthcare utilization. “If you look at the
typical benefit design, you will see costsharing is done in as one-size-fits-all.”

Recent findings reveal that V-BID plans
tend be more generous; target high-risk
individuals; offer wellness programs; and
have a greater impact on adherence than
other plans.2 V-BID is included in the
Affordable Care Act (ACA), and Selected
Preventive Services without Cost-Sharing
(ACA Sec 2713)is the more popular and
non-partisan aspect of ACA. Fendrick
concluded his presentation by describing
the ongoing policy and implementation
challenges and achievements.

Fendrick went on to discuss the impact of
high co-pays and coinsurance, which have
a profound effect on medication adherence
in important classes of drugs. High copays also increase disparities among
economically vulnerable individuals and
those with chronic conditions.
“Clinical nuance” is a term that Fendrick
weaves into V-BID as an important
characteristic of a plan and critical to
healthcare transformation. Basically, clinical
nuance is focused on making sure that
the patient gets to the right provider at the
right time – the service depends on who
receives it and who provides it. “Clinical
nuance acknowledges that medical
services are different in the clinical benefit

Grandon Society Workshop Dr. Fendrick’s
dynamic and humorous demeanor helped
to provide a lively session for Grandon
Society Members. He emphasized that it is
far easier to cut cost than to reduce waste.
He encouraged the audience to move
away from the “one size fits all” model. He
stated that the healthcare delivery system
is the single best employer to put V-BID in
place. Fendrick also shared information on
the Coalition for Smarter Health Care – an
advocacy branch of the Center aimed at
furthering consumer access to high-value,
affordable services.
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